Transdermal drug delivery
By Mark R. Prausnitz, Robert Langer. Nature Biotechnology, 2008
2,506 citations recorded by the source corpus.
Transdermal drug delivery has made an important contribution to medical practice, but has yet to fully achieve its potential as an alternative to oral delivery and hypodermic injections. First-generation transdermal delivery systems have continued their steady increase in clinical use for delivery of small, lipophilic, low-dose drugs. Second-generation delivery systems using chemical enhancers, noncavitational ultrasound and iontophoresis have also resulted in clinical products; the ability of iontophoresis to control delivery rates in real time provides added functionality. Third-generation delivery systems target their effects to skin's barrier layer of stratum corneum using microneedles, thermal ablation, microdermabrasion, electroporation and cavitational ultrasound. Microneedles and thermal ablation are currently progressing through clinical trials for delivery of macromolecules and vaccines, such as insulin, parathyroid hormone and influenza vaccine. Using these novel second- and third-generation enhancement strategies, transdermal delivery is poised to significantly increase its impact on medicine.
Subfields: Biophysics, Insect Science, Pharmaceutical Science
View Paper: https://www.semanticscholar.org/paper/90bd2a1238c050a269e542af7a889cc2afcc03f2
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biophysics
In Insect Science
In Pharmaceutical Science
- Ali Khademhosseini
- Xueting Lin
- Seeram Ramakrishna
- B. Homayun
- Irtisha Singh
- Hyo-Jick Choi
- A. Gaharwar
- Shivakalyani Adepu
Citations in the corpus
- Challenges and Recent Progress in Oral Drug Delivery Systems for Biopharmaceuticals (2019, background): “Chemical enhancers include fatty acids, surfactants, terpenes and solvents, which improve skin permeability by disrupting the highly ordered lipids and modifying the stratum corneum microstructure [19,20].”
- Engineered biomaterials for in situ tissue regeneration (2020, positive): “Microneedles can be used to penetrate the skin and deliver therapeutic factors to the dermis 119,120 .”
- Controlled Drug Delivery Systems: Current Status and Future Directions (2021, background): “For patients who are unable to take oral dosage forms or oral medications that cause intolerable side effects, the use of transdermal patches is strongly recommended as a treatment option [17].”